![]() |
|
|
Vol. 280, Issue 2, 754-760, 1997
CURE: Digestive Diseases Research Center, West Los Angeles VA
Medical Center, Department of Medicine and Brain Research Institute,
UCLA School of Medicine, Los Angeles, California
The influence of central injection of a new corticotropin releasing
factor (CRF) antagonist, astressin,
{cyclo(30-33)[D-Phe12,Nle21,38,Glu30,Lys33]r/hCRF12-41)},
on exogenous and endogenous CRF-induced gastric ileus and stimulation
of bowel discharges was investigated in conscious rats. Intracisternal
(ic) CRF (0.6 µg) reduced gastric emptying of a noncaloric solution
to 17.1 ± 4.9% compared with 50.1 ± 4.6% in control group
injected ic with vehicle. Astressin (1, 3 and 10 µg, ic) dose
dependently prevented ic CRF-induced delayed gastric emptying by 33, 100 and 100%, respectively, and had no effect on basal gastric
emptying. Abdominal surgery with cecal manipulation (1 min) reduced
gastric emptying to 19.8 ± 5.5% 3 hr postsurgery compared with
59.9 ± 5.2% after anesthesia alone plus ic vehicle. Astressin
(1, 3 and 10 µg, ic) prevented postoperative gastric ileus by 56, 93 and 92%, respectively. Intracerebroventricular CRF (0.6 µg) and
water-avoidance stress stimulated pellet output (number/60 min) to
5 ± 1 and 11 ± 2, respectively, compared with no fecal
pellet output after icv vehicle and no exposure to stress. Astressin (3 and 10 µg, icv) blocked exogenous CRF action by 47 and 63%,
respectively, and colonic response to stress by 0 and 54%,
respectively. These data indicate that astressin injected into the CSF
at low doses (1-10 µg) has an antagonistic action against CRF and
stress-related alterations of gastrointestinal motor function, without
an intrinsic effect in these in vivo systems. Astressin
may be a useful tool to explore functional CRF-dependent physiological
pathways in specific brain nuclei.
This article has been cited by other articles:
![]() |
M. Larauche, G. Gourcerol, L. Wang, K. Pambukchian, S. Brunnhuber, D. W. Adelson, J. Rivier, M. Million, and Y. Tache Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G215 - G227. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Miragaya and R. B. S. Harris Antagonism of corticotrophin-releasing factor receptors in the fourth ventricle modifies responses to mild but not restraint stress Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R404 - R416. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Czimmer, M. Million, and Y. Tache Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats Am J Physiol Gastrointest Liver Physiol, March 1, 2006; 290(3): G511 - G518. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Sagami, Y Shimada, J Tayama, T Nomura, M Satake, Y Endo, T Shoji, K Karahashi, M Hongo, and S Fukudo Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome Gut, July 1, 2004; 53(7): 958 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Martinez, L. Wang, J. Rivier, D. Grigoriadis, and Y. Tache Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice J. Physiol., April 1, 2004; 556(1): 221 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Huang, X. Pang, K. Karalis, and T. C. Theoharides Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice Cardiovasc Res, July 1, 2003; 59(1): 241 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W Lewis, G. E Hermann, R. C Rogers, and R A. Travagli In vitro and in vivo analysis of the effects of corticotropin releasing factor on rat dorsal vagal complex J. Physiol., August 15, 2002; 543(1): 135 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-C. Chang and M. R. Opp Role of corticotropin-releasing hormone in stressor-induced alterations of sleep in rat Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R400 - R407. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Mertz Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans Gut, July 1, 2002; 51(90001): i29 - 33. [Abstract] [Full Text] |
||||
![]() |
K. Kojima, Y. Naruse, N. Iijima, N. Wakabayashi, S. Mitsufuji, Y. Ibata, and M. Tanaka HPA-axis responses during experimental colitis in the rat Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1348 - R1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, J. Vaughan, P. E. Sawchenko, and W. W. Vale Urocortin III-Immunoreactive Projections in Rat Brain: Partial Overlap with Sites of Type 2 Corticotrophin-Releasing Factor Receptor Expression J. Neurosci., February 1, 2002; 22(3): 991 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kihara, M. Fujimura, I. Yamamoto, E. Itoh, A. Inui, and M. Fujimiya Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats Am J Physiol Gastrointest Liver Physiol, March 1, 2001; 280(3): G406 - G419. [Abstract] [Full Text] [PDF] |
||||
![]() |
E A MAYER The neurobiology of stress and gastrointestinal disease Gut, December 1, 2000; 47(6): 861 - 869. [Full Text] [PDF] |
||||
![]() |
J Jones, J Boorman, P Cann, A Forbes, J Gomborone, K Heaton, P Hungin, D Kumar, G Libby, R Spiller, et al. British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome Gut, November 1, 2000; 47(90002): ii1 - 19. [Full Text] [PDF] |
||||
![]() |
A. Inui Cancer Anorexia-Cachexia Syndrome: Are Neuropeptides the Key? Cancer Res., September 1, 1999; 59(18): 4493 - 4501. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Martínez, J. Rivier, and Y. Taché Peripheral Injection of a New Corticotropin-Releasing Factor (CRF) Antagonist, Astressin, Blocks Peripheral CRF- and Abdominal Surgery-Induced Delayed Gastric Emptying in Rats J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 629 - 634. [Abstract] [Full Text] |
||||
![]() |
T. Nozu, V. Martinez, J. Rivier, and Y. Tache Peripheral urocortin delays gastric emptying: role of CRF receptor 2 Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G867 - G874. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Million, Y. Tache, and P. Anton Susceptibility of Lewis and Fischer rats to stress-induced worsening of TNB-colitis: protective role of brain CRF Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G1027 - G1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Singh, W. Boucher, X. Pang, R. Letourneau, D. Seretakis, M. Green, and T. C. Theoharides Potent Mast Cell Degranulation and Vascular Permeability Triggered by Urocortin Through Activation of Corticotropin-Releasing Hormone Receptors J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1349 - 1356. [Abstract] [Full Text] |
||||
![]() |
F.-C. Chang and M. R. Opp Blockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1998; 275(3): R793 - R802. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Martinez, E. Barquist, J. Rivier, and Y. Tache Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors Am J Physiol Gastrointest Liver Physiol, May 1, 1998; 274(5): G965 - G970. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. MartInez, F. Cuttitta, and Y. Tache Central Action of Adrenomedullin to Inhibit Gastric Emptying in Rats Endocrinology, September 1, 1997; 138(9): 3749 - 3755. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Coutinho, P. M. Plotsky, M. Sablad, J. C. Miller, H. Zhou, A. I Bayati, J. A. McRoberts, and E. A. Mayer Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat Am J Physiol Gastrointest Liver Physiol, February 1, 2002; 282(2): G307 - G316. [Abstract] [Full Text] [PDF] |
||||